Novel digital therapy for amblyopia demonstrates positive phase 3 results

Luminopia One, an investigational digital therapy that allows patients with amblyopia to watch visually modified TV shows and movies to improve vision, has shown positive results, according to a press release from Luminopia. The phase 3 multicenter, randomized, controlled pivotal clinical trial, published in Ophthalmology, was designed to test the safety and efficacy of Luminopia One in patients with amblyopia aged 4 to 7 years. The trial included 105 patients, with 51 randomly assigned to the treatment group and 54 to the placebo group. At 12 weeks, 45 patients in the treatment group had a 1.8-line improvement in best corrected visual acuity in the weak eye compared with a 0.8-line improvement in BCVA in the control group.

This entry was posted in amblyopia, eHealth. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s